Shattuck Labs
Amy Gibbs Franke has over 20 years of experience in the pharmaceutical and clinical research industries. Amy has held various leadership positions, including Vice President of Clinical Operations, at several companies such as Shattuck Labs, Aravive Inc., and NervGen Pharma Corp. Amy has also worked as a Clinical Research Consultant and held senior director and director roles in strategy and planning, clinical strategy, and project management at companies like Covance, PAREXEL, Novella Clinical Inc., OSI Pharmaceuticals, Cell Pathways, and Genomics Collaborative.
Amy Gibbs Franke obtained a B.S. in Cellular & Molecular Biology from the University of Michigan, completed from 1993 to 1997. Later, they pursued a degree in Bioethics, earning an MBE from the University of Pennsylvania School of Medicine, studying from 2001 to 2006.
This person is not in any offices
Shattuck Labs
Shattuck is a clinical-stage biotechnology company pioneering the development of bifunctional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease.